Fungal infection in the immunocompromised patient. Dr Kirsty Dodgson

Similar documents
Common Fungi. Catherine Diamond MD MPH

ECMM Excellence Centers Quality Audit

Fungal update. Liise-anne Pirofski, M.D. Albert Einstein College of Medicine

HAEMATOLOGY ANTIFUNGAL POLICY

Epidemiology and ecology of fungal diseases

Fungal Infections: Reporting. Marcie Tomblyn, MD, MS Associate Member, Moffitt Cancer Center

Pulmonary Infections: Fungus. Part I: Background Information and Dimorphic Fungus. Part II: Opportunistic Yeast and Molds

Prophylaxis versus Diagnostics-driven approaches to treatment of Invasive fungal diseases. Y.L. Kwong Department of Medicine University of Hong Kong

Fungal biology. Fungal Infections. Fungal cell structure. Pathogenesis

Introduction. Study of fungi called mycology.

Condition First line Alternative Comments Candidemia Nonneutropenic adults

Title: Author: Speciality / Division: Directorate:

Fungal infections in ICU. Tang Swee Fong Department of Paediatrics Universiti Kebangsaan Malaysia

Fungal biology. Pathogenesis. Fungal cell structure. Fungal Infections MID 25 & 26. Eukaryotic (organized nucleus and cell structure) Non-motile

Mycobacteria and fungal infections of the respiratory tract

Pathogens with Intermediate Virulence Dermatophytes opportunistic Pathogens

Case Studies in Fungal Infections and Antifungal Therapy

MANAGEMENT OF HOSPITAL-ACQUIRED FUNGAL INFECTIONS

Management of fungal infection

Rheem Totah, Office H172M, Ph Office hours MWF 11:30 12:20 or by arrangement

Research priorities in medical mycology

ASPERGILLOSIS IN THE NON-NEUTROPENIC HOST

Pneumocystis. Pneumocystis BIOL Summer Introduction. Mycology. Introduction (cont.) Introduction (cont.)

Fungal Infection Post-Infusion Data

WHICH ANTIFUNGAL AGENT IS THE CHOICE FOR SUSPECTED FUNGAL INFECTIONS?

Opportunistic Mycoses

Fungal Infections. Alessandro Diana November 22th 2007

PAGL Inclusion Approved at January 2017 PGC

Elements for a Public Summary. [Product Name] 40 mg/ml oral suspension. VI.2.1 Overview of disease epidemiology

Fungal infections and critically ill adults

Voriconazole October 2015 Risk Management Plan. Voriconazole

Introduction Medical Mycology. Prof. Dr. Asem Shehabi Faculty of Medicine University of Jordan

Fungal Infection Pre-Infusion Data

Fungi are eukaryotic With rigid cell walls composed largely of chitin rather than peptidoglycan (a characteristic component of most bacterial cell

CURRENT AND NEWER ANTI-FUNGAL THERAPIES- MECHANISMS, INDICATIONS, LIMITATIONS AND PROBLEMS. Dr AMIT RAODEO DM SEMINAR

Candiduria in ICU : when and how to treat? Dr. Debashis Dhar Dept of Critical Care and Emergency Medicine Sir Ganga Ram Hospital

Antifungal Update 2/22/12. Which is the most appropriate initial empirical therapy in a candidemic patient?

Antimicrobial prophylaxis in liver transplant A multicenter survey endorsed by the European Liver and Intestine Transplant Association

Neutropenic Sepsis Guideline

Fungal Infections. Fungal Infections

Cigna Drug and Biologic Coverage Policy

Mycological Profile of Bronchial Wash Specimens in Patients with Lower Respiratory Tract Infections

Trust Guideline for the Use of Antifungals in Adults

Lethal pulmonary fungal disease think fungus early

Antifungal Update. Candida: In Vitro Antifungal Susceptibility Testing

ADEQUATE ANTIFUNGAL USE FOR BLOODSTREAM INFECTIONS

High risk neutropenic patient (anticipated duration > 10 days) Send blood twice weekly for Beta -D Glucan Galactomanan Aspergillus PCR

Nationwide survey of treatment for pediatric patients with invasive fungal infections in Japan

Latest Press Release. Cloud9games.tk

OPPORTUNISTIC MYCOSES

Use of Antifungal Drugs in the Year 2006"

ESCMID Online Lecture Library. by author. CASE PRESENTATION ECCMID clinical grand round May Anat Stern, MD Rambam medical center Haifa, Israel

EMPIRICAL PRESCRIBING GUIDELINES FOR SYSTEMIC FUNGAL INFECTIONS IN ADULTS - HH (1)/CL(G)/651/13

Antifungal Agents - Cresemba (isavuconazonium), Vfend. Prior Authorization Program Summary

EMERGING FUNGAL INFECTIONS IN IMMUNOCOMPROMISED PATIENTS

PROGRESSI NELLA TERAPIA ANTIFUNGINA. A tribute to Piero Martino

An Update in the Management of Candidiasis

Antifungal Update 2/24/11. Which is the most appropriate initial empirical therapy in a candidemic patient?

Advance laboratory diagnosis of fungal meningitis: A mini review

Use of Antifungals in the Year 2008

Fungal Meningitis. Stefan Zimmerli Institute for infectious diseases University of Bern Friedbühlstrasse Bern

Outline NEW DIAGNOSTIC TOOLS WHY? WHICH TESTS? WHEN TO USE THEM? Documented IFI

Fungi GUIDE TO INFECTION CONTROL IN THE HOSPITAL CHAPTER NUMBER 53: Author Moi Lin Ling, MBBS, FRCPA, CPHQ, MBA

Antifungal drugs Dr. Raz Muhammed

Current options of antifungal therapy in invasive candidiasis

CMV. Inclusions predominantly in endothelial cells. Immunostaining greater sensitivity than H&E alone.

Fungi More or Less Obligately Associated with Humans. Requirements for Designating a Mycosis*

Fungal and Viral Infections

Epidemiology and Laboratory Diagnosis of Fungal Diseases

Study of systemic fungal infections in renal transplant recipients

Antifungal prophylaxis in haematology patients: the role of voriconazole

Summary of the risk management plan (RMP) for Cresemba (isavuconazole)

Fungal Infections in Neutropenic Hematological Disorders

Fungi. Eucaryotic Rigid cell wall(chitin, glucan) Cell membrane ergosterol Unicellular, multicellular Classic fungus taxonomy:

Is pre-emptive therapy a realistic approach?

Antifungals and current treatment guidelines in pediatrics and neonatology

Histopathology Description:

Cryptococcus gattii Fungal Meningitis. By Cassy Hedberg BI 234

Epidemiology of Fungal Diseases

Antifungal therapies differences in agents

The sensitivity of fungal microorganisms to fluconazole is as follows:

Fever. National Pediatric Nighttime Curriculum Written by Debbie Sakai, M.D. Institution: Lucile Packard Children s Hospital

Invasive Fungal Infections in Solid Organ Transplant Recipients

London New Drugs Group APC/DTC Briefing

How to make a fast diagnosis

General History. 林陳 珠 Female 69 years old 住院期間 : ~ Chief Complaint : sudden loss of conscious 5 minutes in the morning.

Cryptococcosis*,** *usually considered to be an opportunistic mycosis that often becomes systemic.

FLUCAND HIKMA PHARMACEUTICALS

Ventilator Associated Pneumonia. ICU Fellowship Training Radboudumc

2/18/19. Case 1. Question

Dr Hamed Alzoubi. Fungal infections

Severe β-lactam allergy. Alternative (use for mild-moderate β-lactam allergy) therapy

number Done by Corrected by Doctor د.حامد الزعبي

Fungal infections. Ematologia. Corrado Girmenia. Ematologia, Azienda Policlinico Umberto I Sapienza University of Rome, Italy

MICROBIOLOGICAL TESTING IN PICU

ESCMID Online Lecture Library. by author

Antifungals in Invasive Fungal Infections: Antifungals in neutropenic patients

Dr Kaniz Fatema. FCPS (Medicine), MD (Critical Care Medicine) Associate Professor Dept of Critical Care Medicine BIRDEM General Hospital

number Done by Corrected by Doctor

Primary Antifungal Prophylaxis in Adult Hematopoietic Stem Cell Transplant Recipients: Current Therapeutic Concepts

Transcription:

Fungal infection in the immunocompromised patient Dr Kirsty Dodgson

Aims Discuss different types of fungi Overview of types of clinical infections Clinical Manifestations

Fungus Includes Moulds Aspergillus Fusarium Dematiaceaous moulds e.g. Exophiala Mucoraceous moulds e.g. Rhizopus Yeasts Candida Pneumocystis Cryptococcus

Epidemiology Moulds are everywhere We breathe them in constantly Soil, vegetation Warm moist humid environments Neutropenic diet tries to reduce risk Crisps Pepper

Candida albicans Most common species isolated from superficial sites and blood. Most pathogenic species. Sensitive to most antifungal agents.

Non-albicans Candida species Many different species, very heterogeneous. Generally: Increasing frequency- multifactorial explanation. Probably less pathogenic than C. albicans. Often more resistant than C. albicans.

Changing Epidemiology ing aggressive therapy, leads to more susceptible patients. Ageing population more susceptible patients Use of prophylactic fluconazole leads to decrease in susceptible sp (e.g. albicans) and replacement with resistant sp (e.g. glabrata).

Skin and mucosa Asymptomatic colonisation Cutaneous candidiasis Chronic mucocutaneous candidiasis Oesophagitis Onychomycosis Oropharyngeal candidiasis Vulvovaginitis

Oesophagitis

Thrush Assocoiated with decrease in normal flora Watch for recurrent cases If occur perform ID and susceptibilities

Invasive Candidiasis Candidaemia Intravascular Catheters Disseminated candidiasis

Hepatosplenic Candidiasis Within the four overlapping forms of invasive candidiasis, there is a distinct clinical picture that has been given a variety of names: Chronic Disseminated Candidiasis (CDC) Hepatosplenic Candidiasis, Hepatic Candidiasis and Granulomatous Hepatitis. However, the other terms are equally valid.

Interestingly this is a condition that affects almost exclusively patients undergoing remission induction chemotherapy or bone marrow transplantation for acute leukemia HS Candidiasis

HS Candidiasis Another remarkable aspect of this condition is that it manifests only on recovery from prolonged periods of neutropenia. The other near constant finding is one of a group of abdominal symptoms. Right upper quadrant tenderness, hepatomegaly, abdominal distension, nausea, vomiting and diarrhoea occur with variable frequency.

HS Candidiasis Liver Function Tests. One of the most consistent biochemical findings in hepatosplenic candidiasis is a marked elevation on serum alkaline phosphatase. White Blood Count. Another commonly reported finding among patients with CDC is rebound leukocytosis Unfortunately, these laboratory changes are very similar to those found in cases of GVHD and sepsisrelated cholestatic liver disease, thus confusing the diagnosis

Deep Organ Candidiasis Abdomen (Peritonitis) Peritoneal Dialysis-related Candida Peritonitis Gut-injury Related Candida Peritonitis Bone & Joint Candidiasis Candida Osteomyelitis Candida Arthritis Brain & Nerves (CNS candidiasis) Neurosurgery-related CNS candidiasis Eye (Endophthalmitis) Gallbladder (Biliary Candidiasis) Heart (Cardiac Candidiasis) Lung (Candida Pneumonia) Kidney & Bladder (Urinary Candidiasis) Fungus Balls in Urinary Tract Asymptomatic Funguria Liver & Spleen (Hepatosplenic Candidiasis) Pancreas (Pancreatic Candidiasis)

Pneumocystis Jiroveci Pneumonia Normal flora in healthy competent individuals Normally seen as a reactivation in immunocompromised patients Traditionally an AIDS defining illness but seen in any immunocompromised pt Haematology, oncology and solid organ transplant pts Previously Pneumocystis carinii (PCP)

PJP Main symptom, exertional dyspnoea Marked desaturation Its actually a fungus Send deep samples for PJP PCR Sputum not ideal but better than nothing BAL is the gold standard

PJP

PJP Rx Treat with Septrin HD Atovaquone suspension - However, oral atovaquone has limited and unpredictable bioavailability Dapsone with trimethoprim - dapsone is given intravenously or occasionally in nebulised form in the treatment of PCP. Clindamycin with primaquine (unlicensed use in the UK) Aerosolised pentamidine isetionate is no longer recommended because it is associated with increased frequency of relapse Must receive 21 days total treatment

Crytococcus Characteristic features: Yeast forms capsule (seen on india ink stain)

Cryptococcus neoformans

Cryptococcus 34 species in the genus C. neoformans only one of real importance though case reports of other sp causing disease. 2 varieties exist: C. neoformans var neoformans and var gattii

Cryptococcus var neoformans found worldwide pigeon droppings soil Serotypes A, D & AD var gattii Tropical and subtropical eucalyptus trees Serotypes B & C

Cryptococcus Disease Organism inhaled-usually no or mild symptoms. pneumonia rare even in immunocompromised Meningitis-strongly neurotropic often subacute onset in immunocompetent Immunocompromised-HIV, transplant

Cryptococcus Diagnosis Microscopy of CSF Culture-CSF, Blood Anitgen-Blood, CSF

Aspergillus Most common mould infection but not all mould infections are aspergillus Diagnostics are poor so clinical diagnosis is key Fungi are angioinvasive so blood/sputum are rarely positive even by PCR Consider B-Glucan and galactomannan based on local policy

Aspergillus

Gram Stain

Sites of Infection Categories Colonization Allergic bronchopulmonary aspergillosis Pulmonary aspergilloma Invasive aspergillosis Sites Involved Sinuses, lungs Sinuses, lungs Pre-existing lung cavity - Pulmonary aspergillosis 1 - CNS aspergillosis - Sinonasal aspergillosis - Osteomyelitis - Endophthalmitis - Endocarditis - Renal abscesses - Cutaneous Others - Cutaneous: burns, post surgical wounds, IV insertion sites, etc. - Otomycosis - Exogenous endophthalmitis - Allergic fungal sinusitis - Urinary tract fungus balls 1This is the most common site of primary invasive aspergillosis.

Aspergilloma Colonise pre-existing cavities May be excised as can erode through and cause haemoptysis

Invasive Apergillosis

Invasive Apergillosis

18 mo girl with leukaemia

Other Moulds Zygomycetes Causes mucormyosis Rhinocerebral mucor, high mortality Fusarium Disseminated infection

THE END